BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24385012)

  • 1. Serum level of Ca 19-9 increases ability of IgG4 test to distinguish patients with autoimmune pancreatitis from those with pancreatic carcinoma.
    van Heerde MJ; Buijs J; Hansen BE; de Waart M; van Eijck CH; Kazemier G; Pek CJ; Poley JW; Bruno MJ; Kuipers EJ; van Buuren HR
    Dig Dis Sci; 2014 Jun; 59(6):1322-9. PubMed ID: 24385012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase diagnostic accuracy in differentiating focal type autoimmune pancreatitis from pancreatic cancer with combined serum IgG4 and CA19-9 levels.
    Chang MC; Liang PC; Jan S; Yang CY; Tien YW; Wei SC; Wong JM; Chang YT
    Pancreatology; 2014; 14(5):366-72. PubMed ID: 25278306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A comparative study on serum immunoglobulin and tumor marker levels in the patients with autoimmune pancreatitis and pancreatobiliary malignancies].
    Yoon H; Kim MH; Won SH; Park DH; Lee SS; Seo DW; Lee SK
    Korean J Gastroenterol; 2013 Jun; 61(6):327-32. PubMed ID: 23877213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of serum IgG, IgG4 and carbonic anhydrase II antibodies in distinguishing autoimmune pancreatitis from pancreatic cancer and chronic pancreatitis.
    Talar-Wojnarowska R; Gąsiorowska A; Olakowski M; Dranka-Bojarowska D; Lampe P; Śmigielski J; Kujawiak M; Grzegorczyk J; Małecka-Panas E
    Adv Med Sci; 2014 Sep; 59(2):288-92. PubMed ID: 25194335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma.
    Pak LM; Schattner MA; Balachandran V; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
    HPB (Oxford); 2018 Feb; 20(2):182-187. PubMed ID: 29033025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of anti-plasminogen binding peptide, anti-carbonic anhydrase II, immunoglobulin G4, and other serological markers for the differentiation of autoimmune pancreatitis and pancreatic cancer.
    Detlefsen S; de Vos JD; Tanassi JT; Heegaard NHH; Fristrup C; Schaffalitzky de Muckadell OB
    Medicine (Baltimore); 2018 Aug; 97(31):e11641. PubMed ID: 30075546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological characteristics of autoimmune pancreatitis and its differential diagnosis from pancreatic cancer by using a combination of carbohydrate antigen 19-9, globulin, eosinophils and hemoglobin.
    Yan T; Ke Y; Chen Y; Xu C; Yu C; Li Y
    PLoS One; 2017; 12(4):e0174735. PubMed ID: 28369140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer.
    Ghazale A; Chari ST; Smyrk TC; Levy MJ; Topazian MD; Takahashi N; Clain JE; Pearson RK; Pelaez-Luna M; Petersen BT; Vege SS; Farnell MB
    Am J Gastroenterol; 2007 Aug; 102(8):1646-53. PubMed ID: 17555461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Immunoglobulin G4 in Discriminating Autoimmune Pancreatitis From Pancreatic Cancer: A Diagnostic Meta-analysis.
    Dai C; Cao Q; Jiang M; Sun MJ
    Pancreas; 2018 Mar; 47(3):280-284. PubMed ID: 29351121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic significance of serum IgG4 levels in patients with autoimmune pancreatitis: a UK study.
    Sadler R; Chapman RW; Simpson D; Soonawalla ZF; Waldegrave EL; Burden JM; Misbah SA; Ferry BL
    Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):139-45. PubMed ID: 21287719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of serum IgG4 in the diagnosis and follow up of autoimmune pancreatitis: A systematic literature review and meta-analysis.
    Morselli-Labate AM; Pezzilli R
    J Gastroenterol Hepatol; 2009 Jan; 24(1):15-36. PubMed ID: 19067780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined measurement of total serum IgG and IgG4 may increase diagnostic sensitivity for autoimmune pancreatitis without sacrificing specificity, compared with IgG4 alone.
    Song TJ; Kim MH; Moon SH; Eum JB; Park DH; Lee SS; Seo DW; Lee SK
    Am J Gastroenterol; 2010 Jul; 105(7):1655-60. PubMed ID: 20010924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Solid Focal Lesions: Differential Diagnosis between Autoimmune Pancreatitis and Pancreatic Cancer.
    Dite P; Novotny I; Dvorackova J; Kianicka B; Blaho M; Svoboda P; Uvirova M; Rohan T; Maskova H; Kunovsky L
    Dig Dis; 2019; 37(5):416-421. PubMed ID: 31079114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new diagnostic endoscopic tool for autoimmune pancreatitis.
    Kamisawa T; Tu Y; Egawa N; Tsuruta K; Okamoto A
    Gastrointest Endosc; 2008 Aug; 68(2):358-61. PubMed ID: 18513718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical strategies for differentiating autoimmune pancreatitis from pancreatic malignancy to avoid unnecessary surgical resection.
    Wu WC; Yao XZ; Jin DY; Wang DS; Lou WH; Qin XY
    J Dig Dis; 2013 Sep; 14(9):500-8. PubMed ID: 23692995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulin G4 associated with number and distribution of extrapancreatic lesions in type 1 autoimmune pancreatitis patients.
    Kaji R; Takedatsu H; Okabe Y; Ishida Y; Sugiyama G; Yonemoto K; Mitsuyama K; Tsuruta O; Sata M
    J Gastroenterol Hepatol; 2012 Feb; 27(2):268-72. PubMed ID: 21929654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical usefulness of serum immunoglobulin G and G4 level in the diagnosis of autoimmune pancreatitis].
    Kang P; Lee KT; Sinn DH; Kim BJ; Lee JS; Lee JK; Rhee JC
    Korean J Gastroenterol; 2008 Nov; 52(5):304-9. PubMed ID: 19077477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer.
    Chari ST; Takahashi N; Levy MJ; Smyrk TC; Clain JE; Pearson RK; Petersen BT; Topazian MA; Vege SS
    Clin Gastroenterol Hepatol; 2009 Oct; 7(10):1097-103. PubMed ID: 19410017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis.
    Dhall D; Suriawinata AA; Tang LH; Shia J; Klimstra DS
    Hum Pathol; 2010 May; 41(5):643-52. PubMed ID: 20149413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Amylase-α2A Autoantibodies in the Diagnosis of Autoimmune Pancreatitis.
    Sánchez Castañón M; Zuliani V; Amodio A; Campagnola P; Granato A; Gabbrielli A; Benini L; López Hoyos M; Frulloni L
    Pancreas; 2015 Oct; 44(7):1078-82. PubMed ID: 26335011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.